DOSE-RANGING AND DOSE-SETTING FOR INVIVO GENETIC TOXICOLOGY STUDIES

被引：0
|
作者：
MACKAY, LM [1 ]
ELLIOTT, BM [1 ]
机构：
[1] ICI CENT TOXICOL LAB,MACCLESFIELD,ENGLAND
来源：
MUTATION RESEARCH | 1993年 / 291卷 / 03期
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：254 / 254
页数：1
相关论文
共 50 条
  • [21] Dose-ranging study of an orlistat tablet formulation
    Schwartz, Susan M.
    Savastano, David M.
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2018, 56 (10) : 476 - 481
  • [22] A dose-ranging study of the behavioural effects of guarana
    Haskell, CF
    Kennedy, DO
    Milne, AL
    Wesnes, KA
    Scholey, AB
    JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A45 - A45
  • [23] DOSE-RANGING ANTIEMETIC TRIAL OF HIGH-DOSE ORAL METOCLOPRAMIDE
    TYSON, LB
    GRALLA, RJ
    KRIS, MG
    YOUNG, CW
    CLARK, RA
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1989, 12 (03): : 239 - 243
  • [24] Adaptive and Model-Based Dose-Ranging Trials: Quantitative Evaluation and Recommendations. White Paper of the PhRMA Working Group on Adaptive Dose-Ranging Studies
    Pinheiro, Jose
    Sax, Frederic
    Antonijevic, Zoran
    Bornkamp, Bjorn
    Bretz, Frank
    Chuang-Stein, Christy
    Dragalin, Vladimir
    Fardipour, Parvin
    Gallo, Paul
    Gillespie, William
    Hsu, Chyi-Hung
    Miller, Frank
    Padmanabhan, S. Krishna
    Patel, Nitin
    Perevozskaya, Inna
    Roy, Amit
    Sanil, Ashish
    Smith, Jonathan R.
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2010, 2 (04): : 435 - 454
  • [25] A dose-ranging study of rapacuronium in pediatric patients
    Meakin, GH
    Meretoja, OA
    Motsch, J
    Taivainen, T
    Wirtavuori, K
    Schönstedt, R
    Perkins, R
    McCluskey, A
    ANESTHESIOLOGY, 2000, 92 (04) : 1002 - 1009
  • [26] Validation of intra-patient dose escalation methodology for dose-ranging studies in combination chemotherapy.
    Poole, C
    Jordan, S
    Archer, V
    Steven, N
    ANNALS OF ONCOLOGY, 2000, 11 : 141 - 141
  • [27] DOSE-RANGING TRIAL OF ZACOPRIDE - THE EMETIC ANTIEMETIC
    PISTERS, KMW
    KRIS, MG
    TYSON, LB
    CLARK, RA
    GRALLA, RJ
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (09) : 717 - 718
  • [28] Discussion of the paper "adaptive dose-ranging designs"
    Burman, Carl-Fredrik
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2007, 17 (06) : 1005 - 1011
  • [29] A confirmatory dose-ranging study of riluzole in ALS
    Lacomblez, L
    Bensimon, G
    Leigh, PN
    Guillet, P
    Powe, L
    Durrleman, S
    Delumeau, JC
    Meininger, V
    Puech, AJ
    Whitehead, J
    Asselain, B
    Cesaro, P
    Larrey, D
    Rossor, M
    Zimmerman, HJ
    Salzman, P
    Doppler, V
    Lloyd, CM
    Maloteaux, JM
    Delwaide, C
    Laterre, EC
    Bouchard, JP
    Duquette, P
    Girard, M
    Masse, C
    Eisen, A
    Blin, O
    Azulay, JP
    BilleTurc, F
    Pouget, J
    Bouche, P
    Camu, M
    Carlander, B
    Billiard, M
    Clanet, M
    Angibaud, G
    ArneBes, MC
    Benazet, M
    Couratier, P
    Vallat, JM
    Desnuelle, C
    Lagueny, A
    Ellie, E
    Dib, M
    Rozier, A
    Salachas, F
    Viader, F
    Delaunay, D
    Dengler, R
    Kuther, G
    NEUROLOGY, 1996, 47 (06) : S242 - S250
  • [30] Data Monitoring in Adaptive Dose-Ranging Trials
    Gallo, Paul
    Fardipour, Parvin
    Dragalin, Vladimir
    Krams, Michael
    Littman, Gary S.
    Bretz, Frank
    STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2010, 2 (04): : 513 - 521
12345